Studies have suggested that ginsenoside Rg1 may ameliorate OS injury, reduce neuroinflammation, protect neurons, and ultimately enhance cognitive function impaired by AD; this may be attributed to its influence on the Wnt/GSK-3β/β-catenin signaling pathway [117]. This evidence concerns the gene GSK3B and Alzheimer disease.